Exenatide promotes weight loss when added to diet and exercise

Jun 11, 2009

In combination with diet and exercise, the diabetes drug exenatide helped nondiabetic, obese individuals lose over three times more weight than those receiving a placebo, or dummy treatment, for 6 months.

Previous studies show that exenatide, an injectable medication marketed as Byetta (Amylin Pharmaceuticals and Eli Lilly and Company), not only lowers blood sugar but also can result in in some people with diabetes. This study, financed by both pharmaceutical companies, is "the first to assess the effect of exenatide on body weight in nondiabetic obese individuals," said the principal investigator, Michael Trautmann, MD, a researcher with Eli Lilly in Indianapolis.

"Drug therapy is considered important adjunctive treatment to diet and exercise in the successful management of obesity," Trautmann said. "To date, however, there are few effective drugs that help obese people lose weight."

Trautmann and colleagues studied 152 patients in the United States—27 men and 125 women—who were obese (, or BMI, greater than 30). The study subjects had an average weight of about 241 pounds (108.6 kilograms) and an average BMI of 39.6. Of the 152 subjects, 38 (25%) had impaired glucose tolerance. None of the subjects took another weight loss medication during the study or in the several months preceding the study.

Subjects were randomly assigned to receive an injection of either exenatide, 10 micrograms twice a day (73 subjects), or placebo (79 subjects), along with a structured lifestyle modification program involving diet and exercise, for 24 weeks. Neither the subjects nor the staff giving the treatments knew which individuals received the study medication. There was no statistically significant difference in beginning weight between the exenatide-treated subjects and the control subjects, who got the placebo injection.

Individuals who received exenatide lost more weight in 24 weeks than controls did, the authors reported. Those who received the medication lost an average of more than 11 pounds (5.06 kg), whereas the controls lost just 3.5 pounds (1.61 kg). This difference was statistically significant and noted as early as week 8. Only exenatide-treated subjects lost more than 10 percent of their body weight (seven of 73 subjects, or 9.6%).

The most common side effects of exenatide were mild or moderate nausea and diarrhea, but weight loss was independent of nausea, the authors reported. Although exenatide lowers blood glucose, or sugar, levels in people with diabetes, it is known to only act in the presence of high blood glucose so that no subjects reported low blood sugar.

Possible reasons why exenatide may cause weight loss include decreased food intake and increased feelings of fullness, he explained.

Source: The Endocrine Society (news : web)

Explore further: Should men cut back on their soy intake?

Related Stories

Portion-control dishes may help obese diabetics lose weight

Jun 25, 2007

A plate and cereal bowl with markers for proper portion sizes appear to help obese patients with diabetes lose weight and decrease their use of glucose-controlling medications, according to a report in the June 25 issue of ...

Weight loss reduces incontinence for women

Jan 28, 2009

Starting a weight-loss regimen significantly reduces urinary incontinence for women, according to researchers at the University of Alabama at Birmingham (UAB) and the University of California, San Francisco.

Fatty liver disease medication may have no effect

Jan 13, 2009

A new randomized, prospective trial has shown that orlistat, a commonly prescribed inhibitor of fat absorption, does not help patients with fatty liver disease (FLD) lose weight, nor does it improve their liver enzymes or ...

Recommended for you

Should men cut back on their soy intake?

1 hour ago

Recently, a friend called my husband to inquire about the risks for men in consuming too much soy milk. He had read an article that described how one individual's plight led him down the path of breast enlargement, and was ...

Probing Question: What is umami?

2 hours ago

The next time you're at a dinner party and want to spice up the conversation, you might compliment the hosts on their umami-rich appetizers. Then wait a moment until someone invariably asks, "What's umami?"

Will the Affordable Care Act eliminate health disparities?

3 hours ago

Massachusetts' health reform may be a crystal ball for researchers and policymakers in forecasting the potential impact of the Affordable Care Act. Many see the ACA as the backbone of efforts toward closing the nation's health ...

Experts question election pledges on GP access

14 hours ago

As the general election in the UK approaches, experts writing in The BMJ this week question whether the party promises on access to general practice are likely to be achievable.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.